Expedited IRT support for COVID-19 clinical trials
Our 25 years of experience and strong scientific and technical expertise helps our clients to analyze project IRT needs promptly, which helps to reduce study launch timelines further.
By enabling IRT “direct-to-patient” delivery of treatment, we can facilitate patient participation in clinical trials and contribute to the success of these trials.
We can help our clients to overcome COVID-19 challenges and expedite treatment development.
The current pandemic situation requires immediate research and development response. Powerful and fast support to clinical development becomes crucial.
S-Clinica's ClinVision suite is powered by the most powerful algorithm in this
industry, delivering an unrivalled capacity to reduce system setup timelines and
the ability to offer a fully functional system for patient randomization and supplies management, plus the ability to deploy within very short timelines.
The effect of the pandemic on non-COVID-19 clinical trials has also been significant.
In the ever changing world full of uncertainty the COVID-19 pandemic will make an unprecedented difference to the world of clinical trials. This makes planning for the future even more uncertain and complex. S-CLINICA is transforming any study scenario to Simplicity, Control and Cost Benefits.
Watch this video for more information.